Actively Recruiting
Project 4: Ambulatory Biofeedback and Voice Therapy for Patients With Vocal Hyperfunction
Led by Massachusetts General Hospital · Updated on 2025-05-11
100
Participants Needed
2
Research Sites
265 weeks
Total Duration
On this page
Sponsors
M
Massachusetts General Hospital
Lead Sponsor
B
Boston Medical Center
Collaborating Sponsor
AI-Summary
What this Trial Is About
Vocal hyperfunction (VH) is the most commonly treated class of voice disorders by speech-language pathologists and voice therapy is the primary curative treatment. Patients and clinicians report that generalizing improved voicing into daily life is the most significant barrier to successful therapy. We will test if extending biofeedback into the patient's daily life using ambulatory voice monitoring will significantly improve generalization during therapy and if individual patient factors, like how easily they can modify their voice and engagement during therapy, moderate the effects of the biofeedback.
CONDITIONS
Official Title
Project 4: Ambulatory Biofeedback and Voice Therapy for Patients With Vocal Hyperfunction
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of vocal fold nodules and polyps
- Secondary diagnosis of laryngopharyngeal reflux (LPR) or gastro-esophageal reflux disease (GERD)
- Secondary diagnoses related to phonotrauma such as erythema, edema, varices, ectasia, laryngitis, secondary/reactive muscle tension dysphonia (MTD), hemorrhage
- Diagnosis of primary muscle tension dysphonia (MTD)
- Allowable secondary diagnoses include LPR and GERD
You will not qualify if you...
- Any secondary diagnosis not related to phonotrauma, such as cyst, sulcus, cancer, bamboo nodule, known or suspected paralysis
- Secondary diagnoses related to pathological structures like nodules, polyps, edema, cancer
- Neurological conditions such as paralysis or Parkinson's Disease
- Respiratory conditions like chronic cough or paradoxical vocal fold motion
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
Actively Recruiting
2
Boston Medical Center
Boston, Massachusetts, United States, 02118
Actively Recruiting
Research Team
J
Jarrad Van Stan, PhD, CCC-SLP
CONTACT
R
Robert Hillman, PhD, CCC-SLP
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here